Low plasma levels of cholecalciferol and 13-cis-retinoic acid in tuberculosis: Implications in host-based chemotherapy

Nutrition

Volumn 29, Issue 10, 2013, Pages 1245-1251

  Srinivasan, Anand ^a   Syal, Kirtimaan ^a   Banerjee, Dibyajyoti ^a   Hota, Debasish ^a   Gupta, Dheeraj ^a   Kaul, Deepak ^a   Chakrabarti, Amitava ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

13 cis retinoic acid; Cholecalciferol; Tuberculosis

Indexed keywords

ADENOSINE DEAMINASE; COLECALCIFEROL; ISOTRETINOIN; TUBERCULOSTATIC AGENT;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFECTION CONTROL; INTENSIVE CARE; LUNG EMBOLISM; MALE; PLEURA FLUID; PRIORITY JOURNAL; SPUTUM ANALYSIS; TUBERCULOSIS; VITAMIN BLOOD LEVEL;

MYCOBACTERIUM TUBERCULOSIS;

13-CIS-RETINOIC ACID; CHOLECALCIFEROL; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; ISOTRETINOIN; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; VITAMIN A DEFICIENCY; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84884208810     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2013.03.018     Document Type: Article

References (51)

1. Dye C., Scheele S., Dolin P., Pathania V., Raviglione M.C. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999, 282:677-686.
2. Donald P.R., van Helden P.D. The global burden of tuberculosis-combating drug resistance in difficult times. N Engl J Med 2009, 360:2393-2395.
3. Chauhan L.S., Tonsing J. Revised national TB control programme in India. Tuberculosis 2005, 85:271-276.
4. Khatri G.R., Frieden T.R. Controlling tuberculosis in India. N Engl J Med 2002, 347:1420-1425.
5. Gumbo T. Chemotherapy of tuberculosis, mycobacterium avium complex disease, and leprosy. Goodman and Gilman's the pharmacological basis of therapeutics 2010, McGraw-Hill Professional, New York. 12 edition. L. Brunton, B. Chabner, B. Knollman (Eds.).
6. Peloquin C.A. Pharmacological issues in the treatment of tuberculosis. Ann N Y Acad Sci 2001, 953:157-164.
7. Ginsberg A.M., Spigelman M. Challenges in tuberculosis drug research and development. Nat Med 2007, 13:290-294.
8. Peloquin C.A. Therapeutic drug monitoring in the treatment of tuberculosis. Drugs 2002, 62:2169-2183.
9. Green M. Cod liver oil and tuberculosis. BMJ 2011, 343:d7505.
10. Linday L.A. Cod liver oil, young children, and upper respiratory tract infections. J Am Coll Nutr 2010, 29:559-562.
11. Anand P.K., Kaul D. Downregulation of TACO gene transcription restricts mycobacterial entry/survival within human macrophages. FEMS Microbiol Lett 2005, 250:137-144.
12. Anand P.K., Kaul D., Sharma M. Synergistic action of vitamin D and retinoic acid restricts invasion of macrophages by pathogenic mycobacteria. J Microbiol Immunol Infect 2008, 41:17-25.
13. Gibney K.B., MacGregor L., Leder K., Torresi J., Marshall C., Ebeling P.R., Biggs B.A. Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin Infect Dis 2008, 46:443-446.
14. Sasidharan P.K., Rajeev E., Vijayakumari V. Tuberculosis and vitamin D deficiency. J Assoc Physicians India 2002, 50:554-558.
15. Nnoaham K.E., Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 2008, 37:113-119.
16. Lukyanenko Y.O., Chen J.J., Hutson J.C. Production of 25-hydroxycholesterol by testicular macrophages and its effects on Leydig cells. Biol Reprod 2001, 64:790-796.
17. Sakaki T., Kagawa N., Yamamoto K., Inouye K. Metabolism of vitamin D3 by cytochromes P450. Front Biosci 2005, 10:119-134.
18. Trang H.M., Cole D.E., Rubin L.A., Pierratos A., Siu S., Vieth R. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr 1998, 68:854-858.
19. Stubbs J.R., Idiculla A., Slusser J., Menard R., Quarles L.D. Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD. J Am Soc Nephrol 2010, 21:353-361.
20. Amestejani M., Salehi B.S., Vasigh M., Sobhkhiz A., Karami M., Alinia H., et al. Vitamin D supplementation in the treatment of atopic dermatitis: a clinical trial study. J Drugs Dermatol 2012, 11:327-330.
21. Ramachandran G., Santha T., Garg R., Baskaran D., Iliayas S.A., Venkatesan P., et al. Vitamin A levels in sputum-positive pulmonary tuberculosis patients in comparison with household contacts and healthy "normals.". Int J Tuberc Lung Dis 2004, 8:1130-1133.
22. Germain P., Chambon P., Eichele G., Evans R.M., Lazar M.A., Leid M., et al. International Union of Pharmacology. LXIII. Retinoid X receptors. Pharmacol Rev 2006, 58:760-772.
23. McCormick A.M., Kroll K.D., Napoli J.L. 13-cis-retinoic acid metabolism invivo. The major tissue metabolites in the rat have the all-trans configuration. Biochemistry 1983, 22:3933-3940.
24. Blaner W.S. Cellular metabolism and actions of 13-cis-retinoic acid. J Am Acad Dermatol 2001, 45:S129-S135.
25. Marill J., Idres N., Capron C.C., Nguyen E., Chabot G.G. Retinoic acid metabolism and mechanism of action: a review. Curr Drug Metab 2003, 4:1-10.
26. Karadag A.S., Ertugrul D.T., Bilgili S.G., Takci Z., Akin K.O., Calka O. Immunoregulatory effects of isotretinoin in patients with acne. Br J Dermatol 2012, 167:433-435.
27. Barnes P.F., Modlin R.L., Bikle D.D., Adams J.S. Transpleural gradient of 1,25-dihydroxyvitamin D in tuberculous pleuritis. J Clin Invest 1989, 83:1527-1532.
28. Liang Q.L., Shi H.Z., Wang K., Qin S.M., Qin X.J. Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis. Respir Med 2008, 102:744-754.
29. Thompson M., Ellison S.L.R., Wood R. Harmonized guidelines for single-laboratory validation of methods of analysis (IUPAC Technical Report). Pure Appl Chem 2002, 74:835-855.
30. Aksnes L. Simultaneous determination of retinol, alpha-tocopherol, and 25-hydroxyvitamin D in human serum by high-performance liquid chromatography. J Pediatr Gastroenterol Nutr 1994, 18:339-343.
31. Frolik C.A., Tavela T.E., Peck G.L., Sporn M.B. High-pressure liquid chromatographic determination of 13-cis-retinoic acid and all-trans-retinoic acid in human plasma. Anal Biochem 1978, 86:743-750.
32. Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am 2010, 39:365-379. , table of contents.
33. Schoenborn J.R., Wilson C.B. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 2007, 96:41-101.
34. Koeffler H.P., Reichel H., Bishop J.E., Norman A.W. gamma-Interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages. Biochem Biophys Res Commun 1985, 127:596-603.
35. Means T.K., Wang S., Lien E., Yoshimura A., Golenbock D.T., Fenton M.J. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 1999, 163:3920-3927.
36. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
37. Koeffler H.P., Amatruda T., Ikekawa N., Kobayashi Y., DeLuca H.F. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues. Cancer Res 1984, 44:5624-5628.
38. Pino-Lagos K., Guo Y., Noelle R.J. Retinoic acid: a key player in immunity. Biofactors 2010, 36:430-436.
39. Ellison J.B. Intensive Vitamin Therapy in Measles. Br Med J 1932, 2:708-711.
40. Villamor E., Fawzi W.W. Effects of vitamin a supplementation on immune responses and correlation with clinical outcomes. Clin Microbiol Rev 2005, 18:446-464.
41. Al-Attiyah R., El-Shazly A., Mustafa A.S. Comparative analysis of spontaneous and mycobacterial antigen-induced secretion of Th1, Th2 and pro-inflammatory cytokines by peripheral blood mononuclear cells of tuberculosis patients. Scand J Immunol 2012, 75:623-632.
42. Papakonstantinou E., Aletras A.J., Glass E., Tsogas P., Dionyssopoulos A., Adjaye J., et al. Matrix metalloproteinases of epithelial origin in facial sebum of patients with acne and their regulation by isotretinoin. J Invest Dermatol 2005, 125:673-684.
43. Sheen P., O'Kane C.M., Chaudhary K., Tovar M., Santillan C., Sosa J., et al. High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation. Eur Respir J 2009, 33:134-141.
44. Nelson A.M., Zhao W., Gilliland K.L., Zaenglein A.L., Liu W., Thiboutot D.M. Neutrophil gelatinase-associated lipocalin mediates 13-cis retinoic acid-induced apoptosis of human sebaceous gland cells. J Clin Invest 2008, 118:1468-1478.
45. Saiga H., Nishimura J., Kuwata H., Okuyama M., Matsumoto S., Sato S., et al. Lipocalin 2-dependent inhibition of mycobacterial growth in alveolar epithelium. J Immunol 2008, 181:8521-8527.
46. Sanchez-Martinez R., Castillo A.I., Steinmeyer A., Aranda A. The retinoid X receptor ligand restores defective signalling by the vitamin D receptor. EMBO Rep 2006, 7:1030-1034.
47. Ferrari G., Langen H., Naito M., Pieters J. A coat protein on phagosomes involved in the intracellular survival of mycobacteria. Cell 1999, 97:435-447.
48. Shetty N., Shemko M., Vaz M., D'Souza G. An epidemiological evaluation of risk factors for tuberculosis in South India: a matched case control study. Int J Tuberc Lung Dis 2006, 10:80-86.
49. Martineau A.R. Old wine in new bottles: vitamin D in the treatment and prevention of tuberculosis. Proc Nutr Soc 2012, 71:84-89.
50. Wejse C., Gomes V.F., Rabna P., Gustafson P., Aaby P., Lisse I.M., et al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2009, 179:843-850.
51. Nursyam E.W., Amin Z., Rumende C.M. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones 2006, 38:3-5.